Position in SEER
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$225
-$20 QoQ
Shares Held
134
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2020
22 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in SEER Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026JPMORGAN CHASE & CO holds $16,579,063,537 across 407 Biotechnology names. SEER ranks #359 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INSM |
INSMED Inc
|
24,150,499 | $3,949,089,591 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
4,311,806 | $3,331,473,778 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
7,033,156 | $3,140,585,469 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
6,323,752 | $2,092,339,815 | |
| 5 | NUVL |
Nuvalent, Inc.
|
3,088,349 | $316,401,351 | |
| 6 | JAZZ |
Jazz Pharmaceuticals plc
|
1,204,353 | $227,682,931 | |
| 7 | IONS |
Ionis Pharmaceuticals Inc
|
2,363,567 | $177,480,242 | |
| 8 | TERN |
Terns Pharmaceuticals, Inc.
|
2,869,728 | $151,292,056 |
All Filings in SEER
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $225 | 134 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $245 | 134 | Shares | Defined | 2026-02-11 | |
| 2025-09-30 | $290 | 134 | Shares | Defined | 2025-11-26 | |
| 2025-06-30 | $341,723 | 159,684 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $293,642 | 173,753 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $402,683 | 174,322 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $345,447 | 175,354 | Shares | Defined | 2024-12-26 | |
| 2024-06-30 | $175,866 | 104,683 | Shares | Defined | 2024-12-26 | |
| 2024-03-31 | $220,967 | 116,299 | Shares | Defined | 2024-12-26 | |
| 2023-12-31 | $265,207 | 136,705 | Shares | Defined | 2024-12-26 | |
| 2023-09-30 | $151,457 | 68,533 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $194,118 | 45,461 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $3,155,159 | 817,399 | Shares | Defined | 2023-05-18 | |
| 2022-12-31 | $4,441,656 | 765,803 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $5,880,091 | 759,702 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $6,944,374 | 775,908 | Shares | Defined | 2022-08-11 | |
| 2022-03-31 | $11,594,179 | 760,773 | Shares | Defined | 2022-05-11 | |
| 2021-12-31 | $18,935,332 | 830,133 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $29,477,534 | 853,679 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $28,880,261 | 881,033 | Shares | Defined | 2021-08-12 | |
| 2021-03-31 | $47,434,765 | 948,316 | Shares | Defined | 2021-05-12 | |
| 2020-12-31 | $46,939,438 | 836,114 | Shares | Defined | 2021-02-19 | |
| No filing history on record for this holder in this stock. | ||||||